Sponsored by Intact Vascular
Toba II portal banner

Tack Endovascular System (6F) is FDA approved for SFA and proximal popliteal (3.5-6.0mm RVD) treatment of post-PTA dissections.

Download PDF

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

As the first investigator to enroll a subject in the TOBA II study, Dr. Joseph A. R. Cardenas (Interventional Cardiologist and TOBA II Investigator, Yuma Regional Medical Center) knows that treating peripheral artery disease frequently requires a multi-faceted approach. After enrolling 15-20 subjects in the study, he believes that angioplasty treatments are improved because the Tack Endovascular System® enables focal repair of dissections. Dr. Cardenas reviews two cases using the Tack® implant.

TOBA Clinical Studies Program

Download PDF

Follow @intactvascular

#DissectionsMatter

Learn More at intactvascular.com